Results 71 to 80 of about 8,969,517 (177)
An atypical case of isolated immunoglobulin G4-related sclerosing cholangitis with a cholangiogram resembling primary sclerosing cholangitis [PDF]
An asymptomatic 77-year-old man with intrahepatic bile duct dilation was referred to our hospital. Cholangiography revealed alternations between strictures and dilated segments from the right and left hepatic ducts to the lower bile ducts, with findings ...
Iida, Tadashi +6 more
core +2 more sources
Clinical Practice Guidelines for Peroral Cholangioscopy
Nagai and colleagues present evidence‐based clinical practice guidelines developed by the Japan Biliary Association to support the use of peroral cholangioscopy. The guidelines address indications, procedural standards, diagnostic and therapeutic applications, and adverse event management, providing a practical reference for the safe and effective use ...
Kazumasa Nagai +13 more
wiley +1 more source
A young patient with biliary and urinary disease: What's the unifying diagnosis?
Abstract Introduction Chronic ketamine abuse is a growing public health concern associated with severe organ damage. While ketamine‐induced uropathy and cholangiopathy are well‐documented complications individually, their simultaneous presentation is rare. This dual‐system involvement, however, provides a key diagnostic clue on imaging.
Chung‐Wai Wong, Ho‐Nam Ho
wiley +1 more source
Role of Peroral Cholangioscopy in the Diagnosis of Primary Sclerosing Cholangitis
Primary sclerosing cholangitis (PSC) is characterized by idiopathic biliary stricture followed by progressive cholestasis and fibrosis. When diagnosing PSC, its differentiation from other types of sclerosing cholangitis and cholangiocarcinoma is ...
Toshio Fujisawa +11 more
doaj +1 more source
Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis. Abstract Both immunoglobulin G4‐related disease (IgG4‐RD) and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) are systemic disorders that affect a wide range of organs.
Wenhuan Zeng, Mingxin Bai, Yanying Liu
wiley +1 more source
IgG4-Producing MALT Lymphoma in the Renal Hilum
IgG4-related disease is diagnosed when both the elevation of the serum IgG4 level and invasion of IgG4-positive interstitial cells and sclerosis to a tumor are noted. Some cases have demonstrated malignant disease.
Kota Shimokihara +7 more
doaj +1 more source
ABSTRACT Objectives Accurate diagnosis of biliary strictures remains challenging. This study aimed to develop an artificial intelligence (AI) system for peroral cholangioscopy (POCS) using a Vision Transformer (ViT) architecture and to evaluate its performance compared to different vendor devices, conventional convolutional neural networks (CNNs), and ...
Ryosuke Sato +15 more
wiley +1 more source
ABSTRACT Background and Aims Chronically elevated liver enzymes without a clear etiology remain a frequent diagnostic challenge. This study evaluated the diagnostic yield of liver biopsy in such cases and assessed if laboratory parameters predict histological clarification. Methods We retrospectively analyzed 71 patients with unexplained elevated liver
S. Jaawan +8 more
wiley +1 more source
IgG4-related sclerosing cholangitis: liver biopsy findings
IgG4-related autoimmune disease is a recently recognized clinical entity associated with autoimmune pancreatitis, various systemic extrapancreatic lesions and an elevated serum IgG4 level.1 IgG4-related sclerosing cholangitis (IgG4-SC) is one of the extrapancreatic manifestations of this entity, which needs to be differentiated from primary sclerosing ...
Ryu, Han Suk, Kim, Haeryoung
openaire +2 more sources
Tepotinib‐Induced Cholangitis in a Patient With Non‐Small Cell Lung Cancer: A Case Report
Here, we report the first case of tepotinib‐induced cholangitis. When using MET inhibitors for chemotherapy, attention should be paid not only to treatment effectiveness but also to possible hepatobiliary side effects. ABSTRACT Tepotinib, a mesenchymal epithelial transition factor (MET) tyrosine kinase inhibitor, is used to treat non‐small cell lung ...
Yoshimasa Hachisu +7 more
wiley +1 more source

